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Introduction
The term innate lymphoid cells (ILCs) unifies a group of cells
that are developmentally related and lack most lineage markers.
They share morphological features with lymphocytes but, in
contrast to B and T cells, they do not express recombined antigen
receptors and can therefore be classified as innate immune cells
[1]. In the past years, ILCs have been shown to be critical for
physiological processes like lymphoid organ development [2],
tissue homeostasis [3], early control of pathogens [4], but they can
also promote inflammation if inadequately activated [5,6]. Based
on their cytokine and transcription factor expression profile ILCs
have recently been given a uniform nomenclature, dividing ILCs
in three main groups and thereby broadly reflecting the
classification of T helper cell subsets [7]. The first subset (Group
1 ILCs) depends on expression of T-bet, leading to expression of
IFN-c [8,9]. The second subset (Group 2 ILCs) expresses Gata3
and is characterized by the secretion of type 2 cytokines such as
IL-13 and IL-5 [10,11]. Group 3 ILCs (hereafter referred to as
ILC3s) depend on the expression of the transcription factor
retinoic acid-related orphan nuclear receptor Retinoid acid
receptor-related orphan receptor (ROR)ct for their development
as well as their function and secrete IL-22 and IL-17 [12,13].
The most abundant ILC subtype are natural killer (NK) cells
that can be characterized by expression of specific phenotypic
markers, many of them belonging to the family of natural
cytotoxicity receptors. However, for more recently discovered ILC
subtypes such exclusive markers have yet to be defined. Therefore,
during flow cytometric analysis of ILCs usually a combination of
lineage markers is used to exclude other immune cells. As the
phenotypic appearance of ILCs and their cytokine secretion
pattern in many models resemble that of T cells, the elimination of
T lymphocytes is absolutely critical to analyze phenotypic and
functional properties of ILCs. Hence, many studies have been
conducted using animals deficient for the recombination activating
genes (RAG) 1 or 2, thereby genetically eliminating B and T cells
[5,8].
However, for some experimental models and studies on human
tissues this is not an option, thus T cells have to be excluded by
their expression of T cell specific markers. Using flow cytometry,
separation of ILCs from T cells is most frequently achieved by
staining for CD3, a part of the T cell receptor (TCR) complex. As
T cells are known to modulate their CD3 expression level in
particular following their activation [14] and usually outnumber
the rare ILC subgroups, a clear discrimination between these two
populations is essential.
Based on exemplary analysis of RORct dependent ILC3s, we
show here that exclusion of T cells using solely gating on CD3
leaves a significant contamination with T cells. These T cells were
identified by staining for CD5, a surface marker that is involved in
modulating TCR signaling. Depending on the organ analyzed, the
fraction of T cells within the gated ILC3 population accounted for
up to 80% of the remaining ILC3s, which in certain studies may
falsify subsequent results. Quantitative PCR analysis for the
constant regions of the T cell receptor a and d chain (TRAC and
TRDC) revealed that the remaining CD5+ cells belonged mainly to
the ab T cell lineage. In order to obtain a non-ambiguous
separation of ILCs and T cells, stainings for different T cell surface
molecules need to be combined. We therefore suggest comple-
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menting a CD3 and TCRb staining with an antibody binding the
CD5 molecule.
Results and Discussion
CD5+ fraction remains in the ILC3 gate after exclusion of
T cells using CD3 and TCRb
Besides its importance for ILC3s, RORct is also involved in the
development of T cells, mainly TH17 and cd T cells [13,15].
However, most ILC3 and T cell subsets will subsequently
downregulate the expression of RORct [16]. By breeding a
transgenic mouse expressing the Cre recombinase under the
control of the RORc promoter (driving RORct) to a ROSA26-
stopfl/fl eYFP reporter mouse yielding in RORc-eYFP mice, the fate
of these YFP positive RORct -dependent cells can be mapped
[17].
Using leukocytes isolated both from lymphoid (spleen) and non-
lymphoid organs (colon and lung), we compared different gating
approaches for the efficiency in separating ILC3s and T cells. The
gating strategy involved exclusion of doublets, dead cells and B220
expressing events from CD45+ leukocytes. In order to exclude T
cells, CD3 and TCRb positive events were negatively selected
followed by gating on YFP expressing cells (Figure 1a). Similar
gating approaches are used to characterize both murine and
human ILCs but are often not depicted in any figure or involve
gating out multiple lineage markers in one fluorescent channel
[10,18–20]. However, upon further scrutiny of the assumed
ILC3s, we discovered a significant percentage of these cells to stain
positive for CD5, a molecule described to inhibit the T and B cell
receptor signaling and was historically used as a pan T cell marker.
Whereas in the colon this frequency was relatively low with 43.9%
CD5+ cells within the ILC3 gate, in spleen and lung it reached
78.2% and 68.9%, respectively (Figure 1b). Strikingly, in RORc-
eYFP fate mapping mice deficient for RAG1 no expression of CD5
was detected, suggesting that the CD5+ cells obtained from non-
RAG mice belong to the T cell lineage (Figure 1c). Notably, as
Figure 1. Flow cytometric analysis of ILC3s using RORc-eYFP fatemap mice. (a) Gating strategy for ILC3s in RORc-eYFP mice: after exclusion
of doublets, live CD45+ B2202 CD32 TCRb2 YFP+ cells were selected. (b) The population gated in panel a contains a significant fraction of CD5+ cells
both in spleen, lung and colon. (c) In RORc-eYFP-RAG2/2 mice all YFP+ CD45+ live cells stain negative for CD3, TCRb and also CD5. Representative
plots for n = 3 (mean +/2 s.e.m.).
doi:10.1371/journal.pone.0094196.g001
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CD5 is upregulated upon TCR engagement, it is highly expressed
in activated TCRlow and CD3low T cells, which will appear close
to the ILC gate [21].
CD5+ cells remaining within the CD32 TCRb2 ILC3 gate
consist of ab T cells
To determine the nature of the CD5 expressing CD32 TCRb2
cells, this population was purified by flow cytometric cell sorting
from the spleen (Figure 1a and b). The mRNA levels for the
constant region of the T cell receptor a and d chain (TRAC and
TRDC) were compared to that of CD52 ILC3s, ab and cd T cells
as well as monocytes. As a genetic control we used ILC3s derived
from RORc-eYFP RAG12/2 mice. Whereas CD32 TCRb2 CD52
ILC3s showed minor expression of both TRAC and TRDC
(probably reflecting inevitable contamination from the sort
purification), purified ab and cd T cell populations as expected
transcribed high levels of TRAC or TRDC, respectively (Figure 2).
Strikingly, when analyzing TRAC and TRDC expression levels in
CD32 TCRb2 CD5+ cells we detected high levels of TRAC,
suggesting that this population indeed consisted mainly of ab T
cells.
Conclusions
We conclude that gating on lineage negative cells only using
CD3 is not sufficient to firmly exclude ab T cells from further
analysis. This problem becomes particularly evident, when a CD3
containing ‘‘dump channel’’ is employed, where cells expressing
lineage markers at different intensities are gated out in a single
fluorescence channel. Furthermore, the scarcity of ILCs together
with the high number of T cells, which depending on their
activation status might express different levels of CD3, seems to
cause limits for a separation based on one T cell marker. Thus,
results obtained from contaminated ILC populations will be biased
and T cells will contribute to the detected cytokine levels. This
may not only produce artifacts but also mislead the characteriza-
tion of ILC subsets according to the nomenclature based on
cytokine and transcription factor expression.
Given that within the past years a strong association between
ILC and T cell effector function has been proposed, we suggest
that a thorough separation between these two populations is
essential. Hence, lineage negative gating should not only be
performed using CD3 only, but also CD5, preferably in a separate
fluorescent channel.
Materials and Methods
Mouse strains
RORc-CRE and ROSA-stopfl/fl-eYFP mice, provided by
Andreas Diefenbach, were bred to obtain RORc-eYFP fate
mapping animals. Both strains were crossed to RAG12/2 mice,
purchased from the Jackson Laboratory. Animals were between
the ages of 6 to 16 weeks and kept under specific pathogen free
conditions. All animal experiments were approved by the Swiss
Cantonal Veterinary Office (license 147/2012, Zurich, Switzer-
land).
Cell isolation
Mice were euthanized using CO2 inhalation and perfused with
40 ml cold PBS. Spleen, colon and lung were excised and
processed as described below. Spleens were homogenized by
mechanical disruption and filtered through a 70 mm mesh,
followed by lysis of erythrocytes. Lungs were cut into small
pieces, followed by 60 min of digestion at 37uC with 1 mg/ml
Collagenase D (Roche) and 0.5 mg/ml DNAse (Sigma) in IMDM
containing 25 mM HEPES and 2% fetal calve serum (FCS).
Remaining pieces of tissue were homogenized using syringes and
18 gauge needles, followed by filtration through a 70 mm mesh.
Figure 2. CD5+ positive cells within the ILC3 gate express high
levels of TRAC. Normalized fold expression for TRAC and TRDC
comparing CD5+ and CD52 cells within the ILC3 gate (‘‘CD5+ ILC3s’’,
pregated on CD45+ B2202 CD11b2 CD32 TCRb2 YFP+ cells), ab and cd
T cells, monocytes (Mono) purified from RORc-eYFP mice and ILC3s
derived from RORc-eYFP RAG12/2 mice (ILC3s RAG12/2). Results are
presented relative to those obtained from ILC3s of RORc-eYFP RAG12/2
mice (mean +/2 s.e.m.).
doi:10.1371/journal.pone.0094196.g002
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Colons were separated form the mesenteric fat. Luminal mucus
was removed mechanically followed by incubation in Ca2+ Mg2+
lacking HBSS containing 2% of FCS, 1 mM DTT and 1.35 mM
EDTA for 15 min at 37uC. After further incubation in HBSS
complemented with EDTA for 30 min at 37uC the colons were cut
and digested using 0.4 mg/ml collagenase IV (Sigma Aldrich) for
45 min at 37uC. The samples were then homogenized using a
syringe with an 18 gauge needle and filtered through a 70 mm cell
strainer.
Flow cytometry
All flourochrome-conjugated antibodies used were obtained
either from BD, BioLegend or eBioscience, and stainings were
performed according to standard procedures for 20 minutes at
4uC. In all stainings, dead cells were excluded using an Aqua Live/
Dead fixable staining reagent (Invitrogen), and doublets were
excluded by FSC-A vs FSC-H gating. Analysis was performed
using a LSR II Fortessa (special order research product, BD) with
four laser lines (405 nm, 488 nm, 561 nm and 640 nm). Cell
sorting experiments were carried out using a FACSAria III (BD).
Data analysis was done using FlowJo V9.x (Treestar).
mRNA extraction and quantitative real time PCR
Purified cells were resuspended in Trizol (Invitrogen) and kept
at -80uC. RNA was extracted using the PureLink RNA Micro Kit
(Invitrogen) according to the manufactures. RNA concentration
was determined using a spectrophotometer (NanoDrop). Subse-
quent cDNA synthesis was performed using Superscript II rerverse
transcriptase (Invitrogen) and oligo (dt) primers (PeproTech).
Quantitative analysis was conducted using a SYBR Green master
mix (Roche), TRAC and TRDC specific primers (see below) and
measured by the C1000 Touch thermal cycler (BioRad). mRNA
levels were determined by the cycle threshold values and
normalized to the expression of the Pol2 gene. Primers were
designed using CLC Workbench: TRAC: ACAAGCTT-
CACCTGCCAA forward, GCTTTTCTCAGTCAACGTGG
reverse; TRDC: TAGTCTCCTCATGTCAGCCC reverse,
CTACGACTGCTGTTTGCCA forward. Statistical significance
was determined using the BioRad CFX Manager 3.0.
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